After a nurse practitioner was acquitted of illegally prescribing controlled substances, she sues the United States Government and the Drug Enforcement Administration (DEA) Diversion Investigator. The ...

VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...

The glucagon-like peptide-1 receptor agonists improve glycemia and induce a modest weight loss, but there are doubts over their long-term safety. New drugs such as lorcaserin and phentermine ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Obesity is a severe public health problem, contributing significantly to the global non-communicable disease burden, ...

A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.

Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...

Research reveals groundbreaking results about Mounjaro and Ozempic in weight loss treatment. Here's what you need to know ...

With the holidays past and the new year arrived, we look ahead — to losing weight. For some that resolve theoretically ...

Proponents of Ozempic microdosing claim you'll reap the drug's benefits with fewer side effects. But is taking small doses of GLP-1 agonists safe and effective for weight loss?

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Ozempic and similar drugs are advertised all over the place, from television ads, public transit, audio streaming platforms ...